General Information


DRACP ID  DRACP04861

Peptide Name   Aβ

Sequence  EVHHQKLVFF

Sequence Length  10

UniProt ID  Not available

PubChem CID  Not available

Origin  β-amyloid

Type  Synthetic peptide

Classification

  

Active ACP



Activity Information


Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer



Structure Information


PDB ID  Not available

Predicted Structure  Not available

Helicity  Not available

Linear/Cyclic 

Disulfide/Other Bond  Native peptide

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C62H90N16O14

Absent amino acids  ACDGIMNPRSTWY

Common amino acids  FHV

Mass  144421

Pl  7.71

Basic residues  3

Acidic residues  1

Hydrophobic residues  5

Net charge  2

Boman Index  -826

Hydrophobicity  5

Aliphatic Index  97

Half Life 
  Mammalian: 1 hour
  Yeast: 30 min
  E.coli: >10 hour

Extinction Coefficient cystines  0

Absorbance 280nm  0

Polar residues  0

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 21470139

Title  Anti-angiogenic peptides for cancer therapeutics

Doi 10.2174/138920111796117300

Year  2011

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DRACP is developed by Dr.Zheng's team.